D-Index & Metrics Best Publications
David L. Huso

David L. Huso

Johns Hopkins University
United States

Overview

What is he best known for?

The fields of study he is best known for:

  • Gene
  • Cancer
  • Internal medicine

His main research concerns Cancer research, Microbiology, Carcinogenesis, Molecular biology and Bacteroides fragilis. His Cancer research study combines topics in areas such as Human tumor, Heterologous, Immunology, Germ cell and Telomere. His work deals with themes such as Bacteriolytic Therapy, Anaerobic bacteria, Bacteria and Immune system, which intersect with Microbiology.

His work carried out in the field of Carcinogenesis brings together such families of science as Inflammation, Proinflammatory cytokine, Catabolism, Polyamine Catabolism and Pathology. His Molecular biology research is multidisciplinary, incorporating elements of Nitric oxide synthase, Cardiac muscle, Mutation, Mutant and Gene targeting. His Bacteroides fragilis research is multidisciplinary, incorporating perspectives in Receptor, Colitis, DNA damage and Diarrhea.

His most cited work include:

  • Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome. (1347 citations)
  • A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses (1011 citations)
  • Mutant PIK3CA promotes cell growth and invasion of human cancer cells (727 citations)

What are the main themes of his work throughout his whole career to date?

David L. Huso mostly deals with Cancer research, Carcinogenesis, Internal medicine, Immunology and Cancer. The concepts of his Cancer research study are interwoven with issues in Cancer stem cell, Stem cell, Pathology, Leukemia and Colorectal cancer. His research in Carcinogenesis intersects with topics in Wnt signaling pathway, Colitis, Bacteroides fragilis, Transcription factor and Tumor progression.

His Bacteroides fragilis research is multidisciplinary, relying on both Inflammation and Cytokine. His Internal medicine study incorporates themes from Endocrinology and Oncology. In the field of Immunology, his study on Immune system and Bone marrow overlaps with subjects such as Population.

He most often published in these fields:

  • Cancer research (38.94%)
  • Carcinogenesis (23.08%)
  • Internal medicine (20.19%)

What were the highlights of his more recent work (between 2013-2021)?

  • Cancer research (38.94%)
  • Carcinogenesis (23.08%)
  • Internal medicine (20.19%)

In recent papers he was focusing on the following fields of study:

Cancer research, Carcinogenesis, Internal medicine, Bacteroides fragilis and Stem cell are his primary areas of study. His Cancer research study combines topics from a wide range of disciplines, such as Cancer stem cell, Breast cancer and Cancer. David L. Huso has included themes like Chemokine, CXCL1, Transcription factor and Bacteria in his Carcinogenesis study.

His research integrates issues of Nuclear receptor, Endocrinology and Oncology in his study of Internal medicine. His work in Endocrinology addresses issues such as Haploinsufficiency, which are connected to fields such as Genetically modified mouse, Angiotensin II, Loeys–Dietz syndrome and Losartan. His study in Bacteroides fragilis is interdisciplinary in nature, drawing from both Colitis, Inflammation, Secretion, Microbiology and Colorectal cancer.

Between 2013 and 2021, his most popular works were:

  • Patients with familial adenomatous polyposis harbor colonic biofilms containing tumorigenic bacteria (314 citations)
  • Intratumoral injection of Clostridium novyi-NT spores induces antitumor responses (163 citations)
  • Angiotensin II–dependent TGF-β signaling contributes to Loeys-Dietz syndrome vascular pathogenesis (142 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • Cancer
  • Internal medicine

David L. Huso spends much of his time researching Immunology, Carcinogenesis, Bacteroides fragilis, Cancer research and Inflammation. His studies in Immunology integrate themes in fields like Chondrosarcoma, STAT5, Matrix metalloproteinase and Cell biology. David L. Huso combines subjects such as Colorectal cancer, Colon Adenoma, Colitis and Escherichia coli with his study of Carcinogenesis.

His study ties his expertise on Microbiology together with the subject of Bacteroides fragilis. His work often combines Cancer research and HDAC6 studies. His Inflammation research includes themes of Acquired immune system and Immune system.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome.

Jennifer P. Habashi;Daniel P. Judge;Tammy M. Holm;Ronald D. Cohn.
Science (2006)

1847 Citations

A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses

Shaoguang Wu;Ki Jong Rhee;Ki Jong Rhee;Ki Jong Rhee;Emilia Albesiano;Shervin Rabizadeh.
Nature Medicine (2009)

1565 Citations

Mutant PIK3CA promotes cell growth and invasion of human cancer cells

Yardena Samuels;Luis A. Diaz;Oleg Schmidt-Kittler;Jordan M. Cummins.
Cancer Cell (2005)

1020 Citations

Impaired physiological responses to chronic hypoxia in mice partially deficient for hypoxia-inducible factor 1α

Aimee Y. Yu;Larissa A. Shimoda;Narayan V. Iyer;David L. Huso.
Journal of Clinical Investigation (1999)

785 Citations

Nitric oxide synthase in cardiac sarcoplasmic reticulum

Kai Y. Xu;David L. Huso;Ted M. Dawson;David S. Bredt.
Proceedings of the National Academy of Sciences of the United States of America (1999)

687 Citations

Patients with familial adenomatous polyposis harbor colonic biofilms containing tumorigenic bacteria

Christine M. Dejea;Payam Fathi;John M. Craig;Annemarie Boleij;Annemarie Boleij.
Science (2018)

586 Citations

Combination bacteriolytic therapy for the treatment of experimental tumors

Long H. Dang;Chetan Bettegowda;David L. Huso;Kenneth W. Kinzler.
Proceedings of the National Academy of Sciences of the United States of America (2001)

566 Citations

P53-induced microRNA-107 inhibits HIF-1 and tumor angiogenesis

Munekazu Yamakuchi;Craig D. Lotterman;Clare Bao;Ralph H. Hruban.
Proceedings of the National Academy of Sciences of the United States of America (2010)

511 Citations

Evidence for a critical contribution of haploinsufficiency in the complex pathogenesis of Marfan syndrome

Daniel P. Judge;Nancy J. Biery;Douglas R. Keene;Jessica Geubtner.
Journal of Clinical Investigation (2004)

495 Citations

Polyamine catabolism contributes to enterotoxigenic Bacteroides fragilis-induced colon tumorigenesis.

Andrew C. Goodwin;Christina E. Destefano Shields;Shaoguang Wu;David L. Huso.
Proceedings of the National Academy of Sciences of the United States of America (2011)

432 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing David L. Huso

Harry C. Dietz

Harry C. Dietz

Johns Hopkins University School of Medicine

Publications: 105

Bart Loeys

Bart Loeys

University of Antwerp

Publications: 71

Gregg L. Semenza

Gregg L. Semenza

Johns Hopkins University School of Medicine

Publications: 65

Bert Vogelstein

Bert Vogelstein

Johns Hopkins University

Publications: 48

Dianna M. Milewicz

Dianna M. Milewicz

The University of Texas Health Science Center at Houston

Publications: 47

Francesco Ramirez

Francesco Ramirez

Icahn School of Medicine at Mount Sinai

Publications: 40

Robert M. Hoffman

Robert M. Hoffman

AntiCancer (United States)

Publications: 35

Kenneth W. Kinzler

Kenneth W. Kinzler

Johns Hopkins University

Publications: 34

Gregory G. Germino

Gregory G. Germino

National Institutes of Health

Publications: 32

Stefan Somlo

Stefan Somlo

Yale University

Publications: 31

Daniel B. Rifkin

Daniel B. Rifkin

New York University

Publications: 30

Alan Daugherty

Alan Daugherty

University of Kentucky

Publications: 29

Luis A. Diaz

Luis A. Diaz

Memorial Sloan Kettering Cancer Center

Publications: 28

Vicente E. Torres

Vicente E. Torres

Mayo Clinic

Publications: 26

Lynn Y. Sakai

Lynn Y. Sakai

Oregon Health & Science University

Publications: 25

Alfredo Fusco

Alfredo Fusco

University of Naples Federico II

Publications: 25

Trending Scientists

Dirk Grunwald

Dirk Grunwald

University of Colorado Boulder

Qun Liu

Qun Liu

Huawei Technologies (China)

Oleg I. Lebedev

Oleg I. Lebedev

Centre national de la recherche scientifique, CNRS

Elizabeth D. Getzoff

Elizabeth D. Getzoff

Scripps Research Institute

Helma Wennemers

Helma Wennemers

ETH Zurich

Guangren Qian

Guangren Qian

Shanghai University

Gareth Thomas

Gareth Thomas

Lawrence Berkeley National Laboratory

E P Geiduschek

E P Geiduschek

University of California, San Diego

A.K. Panda

A.K. Panda

Indian Council of Agricultural Research

Jason Flannick

Jason Flannick

Broad Institute

Wolfgang Spielmeyer

Wolfgang Spielmeyer

Commonwealth Scientific and Industrial Research Organisation

Shankar Aswani

Shankar Aswani

Rhodes University

Jon Andoni Duñabeitia

Jon Andoni Duñabeitia

Nebrija University

Richard Gorlick

Richard Gorlick

The University of Texas MD Anderson Cancer Center

Jason Gotlib

Jason Gotlib

Stanford University

Charles W. Engelbracht

Charles W. Engelbracht

University of Arizona

Something went wrong. Please try again later.